Pharmalittle: We’re reading about Lilly’s Zepbound for sleep apnea, the FDA budget, and more
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
The location of initial flares and uric acid deposits of gout is frequently in the extremities.
Some oncologists have called the regimen a new standard of care, while others aren’t convinced that the new first-line pancreatic cancer regimen is worth the…
A new breakthrough by researchers at Anthropic could pave the way for safer AI systems.
Washington-based body says spending plans look unrealistically low and ‘difficult choices’ lie ahead
Major advance promises to accelerate the understanding and improved treatment of a wide range of brain disorders, including stroke, cerebral vascular disorders, brain cancer, Alzheimer’s…
Scientific Reports – Forecasting vaping health risks through neural network model prediction of flavour pyrolysis reactions
The FTC’s ban on non-compete clauses comes at a crucial moment for American healthcare. Here’s who wins and loses from the new rule.
Going behind the and beyond the tech news headlines
STAT series ‘Coercive Care’ looks at pregnancy complications from sickle cell disease and patients who felt pressured to have an unwanted tubal ligation.
https://youtu.be/V-IZ2fbnHAY Stepping into the highly competitive personal audio market, Sonos launches the Ace, their first over-ear headphones. In a landscape dominated by heavyweights like Apple’s…